Author

Bushra Jamil

Associate Professor, Section Head Adult Infectious Diseases, Aga Khan University - Cited by 3,883 - Infectious diseases

Biography

Bushra Jamil is currently working as a Professor in the Department of Internal Medicine. Her research interests includes Medicine.she is serving as an editorial member and reviewer of several international reputed journals.She has successfully completed his Administrative responsibilities.She has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Chitosan capping of CuO nanoparticles: Facile chemical preparation, biological analysis, and applications in dentistry
R Javed, F Rais, M Kaleem, B Jamil, MA Ahmad, T Yu, SW Qureshi, Q AoInternational journal of biological macromolecules 167, 1452-1467, 2021202
49
2021
Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome
KI Masood, M Yameen, J Ashraf, S Shahid, SF Mahmood, A Nasir, ...Scientific reports 11 (1), 22958, 2021202
31
2021
Risk factors for intensive care unit admission and mortality in hospitalized COVID-19 patients
A Ayaz, A Arshad, H Malik, H Ali, E Hussain, B JamilAcute and critical care 35 (4), 249-4, 2020202
25
2020
Outcome of COVID-19 patients with use of tocilizumab: a single center experience
MZ Mushtaq, SBZ Mahmood, B Jamil, A Aziz, SA AliInternational Immunopharmacology 88, 106926, 2020202
22
2020
Development and pharmacological evaluation of vancomycin loaded chitosan films
R Kausar, A Khan, B Jamil, Y ShahzadCarbohydrate Polymers 256, 117565, 2021202
16
2021
Role of awake prone positioning in patients with moderate-to-severe COVID-19: an experience from a developing country
I Khanum, F Samar, Y Fatimah, A Safia, A Adil, H Kiren, N Nosheen, ...Monaldi Archives for Chest Disease 91 (2), 2021202
14
2021
Diversity of carbapenem resistance mechanisms in clinical gram-negative bacteria in Pakistan
L Hadjadj, MA Syed, SA Abbasi, JM Rolain, B JamilMicrobial Drug Resistance 27 (6), 760-767, 2021202
13
2021
Progression of acute kidney injury to chronic kidney disease in sepsis survivors: 1-year follow-up study
A Arshad, A Ayaz, S Rehman, RD Ukrani, I Akbar, B JamilJournal of Intensive Care Medicine 36 (11), 66-70, 2021202
13
2021
Tocilizumab for COVID-19 acute respiratory distress syndrome: outcomes assessment using the WHO ordinal scale
N Nasir, F Mahmood, K Habib, I Khanum, B JamilCureus 12 (12), 2020202
7
2020
Treatment of ARDS and hyperinflammation in COVID-19 with IL-6 antagonist Tocilizumab: a tertiary care experience from Pakistan
Treatment of ARDS and hyperinflammation in COVID-19 with IL- antagonist Tocilizumab: a tertiary care experience from PakistanN Nasir, SF Mahmood, K Habib, I Khanum, B JamilMedRxiv, 2020.0. 23.20134072, 2020202
6
2020
Phylodynamic signatures in the emergence of community-associated MRSA
E Steinig, I Aglua, S Duchene, MT Meehan, M Yoannes, C Firth, ...Proceedings of the National Academy of Sciences 119 (45), e2204993119, 2022202
6
2022
Vasopressin in conjunction with norepinephrine in septic shock: a retrospective cohort study from a low middle-income country
HA Raza, A Arshad, A Ayaz, MHR Raja, F Gauhar, M Khan, B JamilCritical Care Explorations 2 (11), 2020202
5
2020
Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis
Y Gao, Y Zhao, G Guyatt, R Fowler, R Kojan, L Ge, J Tian, J Diaz, M Lado, ...The Lancet Microbe, 2022202
5
2022
Testing for Mycobacterium tuberculosis infection using the QuantiFERON-TB GOLD assay in patients with comorbid conditions in a tertiary care endemic setting
KI Masood, B Jamil, A Akber, M Hassan, M Islam, Z HasanTropical Diseases, Travel Medicine and Vaccines 6 (1), 1-8, 2020202
4
2020
Latent M. tuberculosis infection is associated with increased inflammatory cytokine and decreased suppressor of cytokine signalling (SOCS)‐3 in the diabetic host
KI Masood, M Irfan, Q Masood, M Yameen, B Jamil, N Ram, S Rao, ...Scandinavian Journal of Immunology 95 (), e1313, 2022202
4
2022
Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population
I Khanum, L Kumar, S Awan, B JamilClinical and experimental vaccine research 10 (3), 276, 2021202
4
2021
Predicting development of critical illness in patients with covid-19 presenting to a tertiary care hospital in a developing country
H Jibril, A Arshad, RS Martins, B JamilJ Ayub Med Coll Abbottabad 4 (2), 256-262, 2022202
3
2022
A systematic review on the incidence and mortality of Crimean-Congo Haemorrhagic Fever (CCHF) in Pakistan
H Farooq, N Beveridge, T Fletcher, E Ghani, B Jamil, Z Hasan, A Ikram, ...International Journal of Infectious Diseases 101, 50, 000
2
2020
Transcriptomic profiling of disease severity in patients with COVID-19 reveals role of blood clotting and vasculature related genes
KI Masood, SF Mahmood, S Shahid, N Nasir, N Ghanchi, A Nasir, B Jamil, ...medRxiv, 00.06. 18.013571, 000
2
2020
Genetic Diversity of Staphylococcus aureus Strains from a Tertiary Care Hospital in Rawalpindi, Pakistan
MA Syed, B Jamil, H Ramadan, M Rukan, S Ali, SA Abbasi, TA Woodley, ...Microorganisms 9 (11), 301, 010
2
2021

Referred From: https://scholar.google.com/citations?hl=en&user=RWm66LgAAAAJ

Cited by
Citations 3883
h-index 29
i10-index 66
Recommended Journals
Open Access Journals